| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.061 | 0.04 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.04 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.099 | 0.04 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.076 | 0.05 |